contraindications of glp 1 agonist Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks contraindications to glp 1 agonist
Description
Eggers and Beggs tests were applied to assess funnel plot symmetry quantitatively.29 We also used the CINeMA (Confidence in Network Meta-Analysis) framework to assess the certainty of the evidence in six key areas, including within-study bias, reporting bias, indirectness, imprecision, heterogeneity, and inconsistency.3031 We assessed intransitivity for the CINeMA framework by comparing potential effect modifiers, such as baseline age and HbA 1c concentration, between studies that provided direct and indirect evidence for each comparison
doi: 10.3389/fendo.2021.622737 51 MorettoTMiltonDRidgeTMacconellLOkersonTWolkaAet al
However, more recent evidence shows renoprotective evidence and slowing of chronic kidney disease progression as seen in a meta-analysis released in 2023 [70]
From weight loss breakthroughs to type 2 diabetes management , and even anti-aging medicine , these treatments offer extraordinary promise
however, the average BMI plateaued in 2022 and declined in 2023 (Rader et al., 2024)
Biochem Biophys Res Commun 196: 141-146, 1993
